Results 251 to 260 of about 621,305 (415)

Primary ovarian neuroendocrine neoplasia with concurrent large epithelial borderline ovarian tumor, coexistent with non-malignant pleural effusion and multiple uterine fibroids: a case report and review of the literature. [PDF]

J Med Case Rep
Mohsin M, Dube R, Hamza D, Ali M, Garg H.   +4 more
europepmc   +1 more source

Staging at Diagnosis and Survival of Hematologic Neoplasms in Children and Adolescents in Mato Grosso, Brazil: A Population-based Study

Paulo César Fernandes de Souza, Mariano Martínez Espinosa, Maria Teresa Bustamante-Teixeira, Noemi Dreyer Galvão, Fernanda Cristina da Silva de Lima   +4 more
openalex   +1 more source

Contribution of 18F-FDG PET/CT in the Staging of Pancreatic Solid Pseudopapillary Neoplasms: A Case Report

, 2017
Maurizio Zizzo, Vincenzo De Biasi, Lara Ugoletti, Carolina Castro Ruiz, Stefano Bonacini, Michele Panebianco, Alessandro Giunta, Claudio Pedrazzoli   +7 more
openalex   +2 more sources

A comprehensive validation of the novel 8th edition of American Joint Committee on Cancer staging manual for the long-term survivals of patients with non-functional pancreatic neuroendocrine neoplasms

, 2020
Min Yang, Lin Zeng, Wenqing Yao, Nengwen Ke, Chunlu Tan, Bole Tian, Xu-Bao Liu, Bo Xiang, Yi Zhang   +8 more
openalex   +1 more source

Detecting homologous recombination deficiency for breast cancer through integrative analysis of genomic data

Molecular Oncology, EarlyView.
This study develops a semi‐supervised classifier integrating multi‐genomic data (1404 training/5893 validation samples) to improve homologous recombination deficiency (HRD) detection in breast cancer. Our method demonstrates prognostic value and predicts chemotherapy/PARP inhibitor sensitivity in HRD+ tumours.
Rong Zhu, Katherine Eason, Suet‐Feung Chin, Paul A. W. Edwards, Raquel Manzano Garcia, Richard Moulange, Jia Wern Pan, Soo Hwang Teo, Sach Mukherjee, Maurizio Callari, Carlos Caldas, Stephen‐John Sammut, Oscar M. Rueda   +12 more
wiley   +1 more source

Evaluation of KRAS and NRAS mutations in metastatic colorectal cancer: an 8‐year study of 10 754 patients in Turkey

Molecular Oncology, EarlyView.
This nationwide study evaluated KRAS and NRAS mutations in 10 754 Turkish patients with metastatic colorectal cancer. The results revealed a mutation frequency of 51.1%, with 46.6% having KRAS mutations, 4.5% having NRAS mutations, and 48.5% being wild‐type for both.
Gozde Kavgaci, Izzet Akiva, Yavuz Hakan Ozon, Hakan Berkil, Huseyin Karadayi, Omer Dizdar, Suayib Yalcin   +6 more
wiley   +1 more source

PET/MRI is superior to PET/CT in detecting oesophago and gastric carcinomas: a meta-analysis. [PDF]

Cancer Imaging
Peng B, Sun H, Hou J, Luo JX.
europepmc   +1 more source

Landscape of BRAF transcript variants in human cancer

Molecular Oncology, EarlyView.
We investigate the annotation of BRAF variants, focusing on protein‐coding BRAF‐220 (formerly BRAF‐reference) and BRAF‐204 (BRAF‐X1). The IsoWorm pipeline allows us to quantify these variants in human cancer, starting from RNA‐sequencing data. BRAF‐204 is more abundant than BRAF‐220 and impacts patient survival.
Maurizio S. Podda, Danilo Tatoni, Gianluca Mattei, Alberto Magi, Romina D'Aurizio, Laura Poliseno   +5 more
wiley   +1 more source

Surveillance of low-grade appendiceal mucinous neoplasms for progression to pseudomyxoma peritonei: Results from a structured surveillance programme. [PDF]

Colorectal Dis
Hannan E, Roman LM, O'Brien L, Mueller A, Staunton O, Shields C, Aird J, Mulsow J.   +7 more
europepmc   +1 more source

CT and MR Imaging in the Local Staging of Primary Malignant Musculoskeletal Neoplasms: Report of the Radiology Diagnostic Oncology Group. Radiology 1997; 202:237–246 [PDF]

, 1998
Lynne S. Steinbach
openalex   +1 more source